Birdwatch Archive

Birdwatch Note Rating

2024-12-26 10:02:54 UTC - HELPFUL

Rated by Participant: 43DE7E95D22AC61515C6B9432D34238B3836A0E13B5257D49376AF2842C8A65D
Participant Details

Original Note:

En el tuit mezcla una noticia de inmunización pasiva con el anticuerpo Nirsevimab con excelentes resultados con otra que hace referencia a vacunas (inmunización activa) que están en fase experimental y sin relación (ni técnica ni factual) con la primera https://www.sanidad.gob.es/areas/promocionPrevencion/vacunaciones/comoTrabajamos/docs/Nirsevimab.pdf

All Note Details

Original Tweet

All Information

  • noteId - 1872046979028508935
  • participantId -
  • raterParticipantId - 43DE7E95D22AC61515C6B9432D34238B3836A0E13B5257D49376AF2842C8A65D
  • createdAtMillis - 1735207374779
  • version - 2
  • agree - 0
  • disagree - 0
  • helpful - 0
  • notHelpful - 0
  • helpfulnessLevel - HELPFUL
  • helpfulOther - 0
  • helpfulInformative - 0
  • helpfulClear - 1
  • helpfulEmpathetic - 0
  • helpfulGoodSources - 1
  • helpfulUniqueContext - 0
  • helpfulAddressesClaim - 1
  • helpfulImportantContext - 1
  • helpfulUnbiasedLanguage - 0
  • notHelpfulOther - 0
  • notHelpfulIncorrect - 0
  • notHelpfulSourcesMissingOrUnreliable - 0
  • notHelpfulOpinionSpeculationOrBias - 0
  • notHelpfulMissingKeyPoints - 0
  • notHelpfulOutdated - 0
  • notHelpfulHardToUnderstand - 0
  • notHelpfulArgumentativeOrBiased - 0
  • notHelpfulOffTopic - 0
  • notHelpfulSpamHarassmentOrAbuse - 0
  • notHelpfulIrrelevantSources - 0
  • notHelpfulOpinionSpeculation - 0
  • notHelpfulNoteNotNeeded - 0
  • ratingsId - 187204697902850893543DE7E95D22AC61515C6B9432D34238B3836A0E13B5257D49376AF2842C8A65D